HEADER TRANSCRIPTION 05-JUL-24 9FZI TITLE A NEW CRYSTAL STRUCTURE OF THE HPXR-LBD IN FUSION WITH AN SRC1 CO- TITLE 2 ACTIVATOR PEPTIDE AND IN COMPLEX WITH SR12813 (P212121 FORM) COMPND MOL_ID: 1; COMPND 2 MOLECULE: NUCLEAR RECEPTOR SUBFAMILY 1 GROUP I MEMBER 2,NUCLEAR COMPND 3 RECEPTOR COACTIVATOR 1; COMPND 4 CHAIN: A, B; COMPND 5 SYNONYM: ORPHAN NUCLEAR RECEPTOR PAR1,ORPHAN NUCLEAR RECEPTOR PXR, COMPND 6 PREGNANE X RECEPTOR,STEROID AND XENOBIOTIC RECEPTOR,SXR,NCOA-1,CLASS COMPND 7 E BASIC HELIX-LOOP-HELIX PROTEIN 74,BHLHE74,PROTEIN HIN-2,RIP160, COMPND 8 RENAL CARCINOMA ANTIGEN NY-REN-52,STEROID RECEPTOR COACTIVATOR 1,SRC- COMPND 9 1; COMPND 10 EC: 2.3.1.48; COMPND 11 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: NR1I2, PXR, NCOA1, BHLHE74, SRC1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS NUCLEAR RECEPTOR, LIGAND BINDING DOMAIN, PXR, TRANSCRIPTION EXPDTA X-RAY DIFFRACTION AUTHOR C.CARIVENC,P.BLANC,W.BOURGUET,V.DELFOSSE REVDAT 1 19-FEB-25 9FZI 0 JRNL AUTH C.CARIVENC,G.LACONDE,P.BLANC,M.AMBLARD,W.BOURGUET,V.DELFOSSE JRNL TITL A TWO-IN-ONE EXPRESSION CONSTRUCT FOR BIOPHYSICAL AND JRNL TITL 2 STRUCTURAL STUDIES OF THE HUMAN PREGNANE X RECEPTOR JRNL TITL 3 LIGAND-BINDING DOMAIN, A PHARMACEUTICAL AND ENVIRONMENTAL JRNL TITL 4 TARGET. JRNL REF ACTA CRYSTALLOGR.,SECT.F 2025 JRNL REFN ESSN 2053-230X JRNL PMID 39923198 JRNL DOI 10.1107/S2053230X2500069X REMARK 2 REMARK 2 RESOLUTION. 2.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.18.2_3874 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 44.51 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.370 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.3 REMARK 3 NUMBER OF REFLECTIONS : 22821 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.196 REMARK 3 R VALUE (WORKING SET) : 0.194 REMARK 3 FREE R VALUE : 0.237 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1142 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 44.5100 - 5.4000 1.00 2879 152 0.2007 0.2494 REMARK 3 2 5.4000 - 4.2900 1.00 2736 144 0.1651 0.1800 REMARK 3 3 4.2800 - 3.7400 0.97 2641 139 0.1687 0.2141 REMARK 3 4 3.7400 - 3.4000 1.00 2705 143 0.1819 0.2343 REMARK 3 5 3.4000 - 3.1600 1.00 2673 140 0.2187 0.2651 REMARK 3 6 3.1600 - 2.9700 0.99 2680 141 0.2201 0.2890 REMARK 3 7 2.9700 - 2.8200 1.00 2686 142 0.2350 0.2972 REMARK 3 8 2.8200 - 2.7000 1.00 2679 141 0.2641 0.3184 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.319 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 24.435 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 55.75 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 53.66 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.009 4674 REMARK 3 ANGLE : 1.096 6345 REMARK 3 CHIRALITY : 0.058 709 REMARK 3 PLANARITY : 0.006 797 REMARK 3 DIHEDRAL : 20.929 1755 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 9FZI COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 05-JUL-24. REMARK 100 THE DEPOSITION ID IS D_1292139956. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 09-FEB-23 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.0 - 7.4 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : MASSIF-3 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.967697 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 22821 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.700 REMARK 200 RESOLUTION RANGE LOW (A) : 44.510 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.3 REMARK 200 DATA REDUNDANCY : 6.800 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.10300 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 11.9800 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.77 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.8 REMARK 200 DATA REDUNDANCY IN SHELL : 7.20 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.58100 REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 52.11 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.57 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100 MM IMIDAZOLE 25 - 30% MPD, VAPOR REMARK 280 DIFFUSION, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 42.71000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 53.33000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 44.51500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 53.33000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 42.71000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 44.51500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 119 REMARK 465 LYS A 120 REMARK 465 LYS A 121 REMARK 465 GLY A 122 REMARK 465 HIS A 123 REMARK 465 HIS A 124 REMARK 465 HIS A 125 REMARK 465 HIS A 126 REMARK 465 HIS A 127 REMARK 465 HIS A 128 REMARK 465 GLY A 129 REMARK 465 SER A 130 REMARK 465 GLU A 131 REMARK 465 ARG A 132 REMARK 465 THR A 133 REMARK 465 GLY A 134 REMARK 465 THR A 135 REMARK 465 GLN A 136 REMARK 465 PRO A 137 REMARK 465 LEU A 138 REMARK 465 GLY A 139 REMARK 465 VAL A 140 REMARK 465 VAL A 177 REMARK 465 LEU A 178 REMARK 465 SER A 179 REMARK 465 SER A 180 REMARK 465 GLY A 181 REMARK 465 CYS A 182 REMARK 465 GLU A 183 REMARK 465 LEU A 184 REMARK 465 PRO A 185 REMARK 465 GLU A 186 REMARK 465 SER A 187 REMARK 465 LEU A 188 REMARK 465 GLN A 189 REMARK 465 ALA A 190 REMARK 465 PRO A 191 REMARK 465 ALA A 312 REMARK 465 GLY A 313 REMARK 465 GLY A 314 REMARK 465 GLY A 433 REMARK 465 SER A 434 REMARK 465 LEU A 435 REMARK 465 VAL A 436 REMARK 465 PRO A 437 REMARK 465 ARG A 438 REMARK 465 GLY A 439 REMARK 465 SER A 440 REMARK 465 SER A 441 REMARK 465 SER A 442 REMARK 465 HIS A 443 REMARK 465 SER A 444 REMARK 465 SER A 461 REMARK 465 PRO A 462 REMARK 465 SER A 463 REMARK 465 MET B 119 REMARK 465 LYS B 120 REMARK 465 LYS B 121 REMARK 465 GLY B 122 REMARK 465 HIS B 123 REMARK 465 HIS B 124 REMARK 465 HIS B 125 REMARK 465 HIS B 126 REMARK 465 HIS B 127 REMARK 465 HIS B 128 REMARK 465 GLY B 129 REMARK 465 SER B 130 REMARK 465 GLU B 131 REMARK 465 ARG B 132 REMARK 465 THR B 133 REMARK 465 GLY B 134 REMARK 465 THR B 135 REMARK 465 GLN B 136 REMARK 465 PRO B 137 REMARK 465 LEU B 138 REMARK 465 GLY B 139 REMARK 465 VAL B 140 REMARK 465 GLN B 141 REMARK 465 GLY B 142 REMARK 465 VAL B 177 REMARK 465 LEU B 178 REMARK 465 SER B 179 REMARK 465 SER B 180 REMARK 465 GLY B 181 REMARK 465 CYS B 182 REMARK 465 GLU B 183 REMARK 465 LEU B 184 REMARK 465 PRO B 185 REMARK 465 GLU B 186 REMARK 465 SER B 187 REMARK 465 LEU B 188 REMARK 465 GLN B 189 REMARK 465 ALA B 190 REMARK 465 PRO B 191 REMARK 465 SER B 192 REMARK 465 ARG B 193 REMARK 465 GLU B 194 REMARK 465 THR B 311 REMARK 465 ALA B 312 REMARK 465 GLY B 313 REMARK 465 GLY B 433 REMARK 465 SER B 434 REMARK 465 LEU B 435 REMARK 465 VAL B 436 REMARK 465 PRO B 437 REMARK 465 ARG B 438 REMARK 465 GLY B 439 REMARK 465 SER B 440 REMARK 465 SER B 441 REMARK 465 SER B 442 REMARK 465 HIS B 443 REMARK 465 SER B 444 REMARK 465 SER B 445 REMARK 465 PRO B 462 REMARK 465 SER B 463 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLN A 141 CG CD OE1 NE2 REMARK 470 GLU A 146 CG CD OE1 OE2 REMARK 470 ARG A 152 CD NE CZ NH1 NH2 REMARK 470 LYS A 160 NZ REMARK 470 LYS A 170 CD CE NZ REMARK 470 ARG A 193 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 194 CG CD OE1 OE2 REMARK 470 LYS A 204 CD CE NZ REMARK 470 LYS A 210 CG CD CE NZ REMARK 470 GLU A 218 CD OE1 OE2 REMARK 470 LYS A 226 CG CD CE NZ REMARK 470 SER A 231 OG REMARK 470 LYS A 234 CG CD CE NZ REMARK 470 LYS A 252 CE NZ REMARK 470 GLU A 270 CD OE1 OE2 REMARK 470 GLU A 295 CD OE1 OE2 REMARK 470 ARG A 303 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 309 CG CD OE1 OE2 REMARK 470 ASP A 310 CG OD1 OD2 REMARK 470 THR A 311 OG1 CG2 REMARK 470 PHE A 315 CG CD1 CD2 CE1 CE2 CZ REMARK 470 GLN A 316 CG CD OE1 NE2 REMARK 470 GLN A 317 CG CD OE1 NE2 REMARK 470 LEU A 318 CG CD1 CD2 REMARK 470 LEU A 319 CG CD1 CD2 REMARK 470 LYS A 325 CE NZ REMARK 470 LYS A 332 CD CE NZ REMARK 470 ARG A 360 CD NE CZ NH1 NH2 REMARK 470 GLN A 364 CD OE1 NE2 REMARK 470 GLN A 368 CG CD OE1 NE2 REMARK 470 CYS A 379 SG REMARK 470 GLN A 383 CG CD OE1 NE2 REMARK 470 GLN A 406 CD OE1 NE2 REMARK 470 LEU A 446 CG CD1 CD2 REMARK 470 GLU A 448 CG CD OE1 OE2 REMARK 470 ARG A 449 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 451 CE NZ REMARK 470 GLN A 458 CG CD OE1 NE2 REMARK 470 GLU B 146 CG CD OE1 OE2 REMARK 470 MET B 149 CG SD CE REMARK 470 ARG B 152 CD NE CZ NH1 NH2 REMARK 470 LYS B 170 CE NZ REMARK 470 GLU B 195 CG CD OE1 OE2 REMARK 470 LYS B 198 CG CD CE NZ REMARK 470 GLN B 201 OE1 NE2 REMARK 470 ARG B 203 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 204 CG CD CE NZ REMARK 470 LYS B 210 CG CD CE NZ REMARK 470 GLU B 218 CG CD OE1 OE2 REMARK 470 LYS B 226 CD CE NZ REMARK 470 SER B 231 OG REMARK 470 LYS B 234 CG CD CE NZ REMARK 470 LYS B 277 NZ REMARK 470 GLU B 295 CG CD OE1 OE2 REMARK 470 ARG B 303 CG CD NE CZ NH1 NH2 REMARK 470 GLU B 309 CG CD OE1 OE2 REMARK 470 ASP B 310 CG OD1 OD2 REMARK 470 PHE B 315 CG CD1 CD2 CE1 CE2 CZ REMARK 470 GLN B 316 CG CD OE1 NE2 REMARK 470 GLN B 317 CG CD OE1 NE2 REMARK 470 LEU B 318 CG CD1 CD2 REMARK 470 LEU B 319 CG CD1 CD2 REMARK 470 LYS B 325 CD CE NZ REMARK 470 LYS B 332 CE NZ REMARK 470 ARG B 360 CG CD NE CZ NH1 NH2 REMARK 470 GLN B 364 CG CD OE1 NE2 REMARK 470 LYS B 374 NZ REMARK 470 GLN B 383 CG CD OE1 NE2 REMARK 470 GLN B 406 CD OE1 NE2 REMARK 470 GLN B 409 CD OE1 NE2 REMARK 470 ILE B 417 CG1 CG2 CD1 REMARK 470 GLU B 448 CG CD OE1 OE2 REMARK 470 LYS B 451 CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 CYS A 301 68.53 -108.10 REMARK 500 LEU A 319 7.26 -64.41 REMARK 500 HIS A 386 35.90 -93.26 REMARK 500 PHE A 420 -12.41 -155.22 REMARK 500 ALA B 196 -20.11 -140.83 REMARK 500 LYS B 234 4.77 -66.26 REMARK 500 CYS B 301 68.66 -102.18 REMARK 500 PHE B 349 58.90 -92.01 REMARK 500 ARG B 381 62.08 -115.51 REMARK 500 HIS B 418 86.95 -152.79 REMARK 500 PHE B 420 -9.33 -151.52 REMARK 500 REMARK 500 REMARK: NULL DBREF 9FZI A 130 434 UNP O75469 NR1I2_HUMAN 130 434 DBREF 9FZI A 441 463 UNP Q15788 NCOA1_HUMAN 678 700 DBREF 9FZI B 130 434 UNP O75469 NR1I2_HUMAN 130 434 DBREF 9FZI B 441 463 UNP Q15788 NCOA1_HUMAN 678 700 SEQADV 9FZI MET A 119 UNP O75469 INITIATING METHIONINE SEQADV 9FZI LYS A 120 UNP O75469 EXPRESSION TAG SEQADV 9FZI LYS A 121 UNP O75469 EXPRESSION TAG SEQADV 9FZI GLY A 122 UNP O75469 EXPRESSION TAG SEQADV 9FZI HIS A 123 UNP O75469 EXPRESSION TAG SEQADV 9FZI HIS A 124 UNP O75469 EXPRESSION TAG SEQADV 9FZI HIS A 125 UNP O75469 EXPRESSION TAG SEQADV 9FZI HIS A 126 UNP O75469 EXPRESSION TAG SEQADV 9FZI HIS A 127 UNP O75469 EXPRESSION TAG SEQADV 9FZI HIS A 128 UNP O75469 EXPRESSION TAG SEQADV 9FZI GLY A 129 UNP O75469 EXPRESSION TAG SEQADV 9FZI LEU A 435 UNP O75469 LINKER SEQADV 9FZI VAL A 436 UNP O75469 LINKER SEQADV 9FZI PRO A 437 UNP O75469 LINKER SEQADV 9FZI ARG A 438 UNP O75469 LINKER SEQADV 9FZI GLY A 439 UNP O75469 LINKER SEQADV 9FZI SER A 440 UNP O75469 LINKER SEQADV 9FZI MET B 119 UNP O75469 INITIATING METHIONINE SEQADV 9FZI LYS B 120 UNP O75469 EXPRESSION TAG SEQADV 9FZI LYS B 121 UNP O75469 EXPRESSION TAG SEQADV 9FZI GLY B 122 UNP O75469 EXPRESSION TAG SEQADV 9FZI HIS B 123 UNP O75469 EXPRESSION TAG SEQADV 9FZI HIS B 124 UNP O75469 EXPRESSION TAG SEQADV 9FZI HIS B 125 UNP O75469 EXPRESSION TAG SEQADV 9FZI HIS B 126 UNP O75469 EXPRESSION TAG SEQADV 9FZI HIS B 127 UNP O75469 EXPRESSION TAG SEQADV 9FZI HIS B 128 UNP O75469 EXPRESSION TAG SEQADV 9FZI GLY B 129 UNP O75469 EXPRESSION TAG SEQADV 9FZI LEU B 435 UNP O75469 LINKER SEQADV 9FZI VAL B 436 UNP O75469 LINKER SEQADV 9FZI PRO B 437 UNP O75469 LINKER SEQADV 9FZI ARG B 438 UNP O75469 LINKER SEQADV 9FZI GLY B 439 UNP O75469 LINKER SEQADV 9FZI SER B 440 UNP O75469 LINKER SEQRES 1 A 345 MET LYS LYS GLY HIS HIS HIS HIS HIS HIS GLY SER GLU SEQRES 2 A 345 ARG THR GLY THR GLN PRO LEU GLY VAL GLN GLY LEU THR SEQRES 3 A 345 GLU GLU GLN ARG MET MET ILE ARG GLU LEU MET ASP ALA SEQRES 4 A 345 GLN MET LYS THR PHE ASP THR THR PHE SER HIS PHE LYS SEQRES 5 A 345 ASN PHE ARG LEU PRO GLY VAL LEU SER SER GLY CYS GLU SEQRES 6 A 345 LEU PRO GLU SER LEU GLN ALA PRO SER ARG GLU GLU ALA SEQRES 7 A 345 ALA LYS TRP SER GLN VAL ARG LYS ASP LEU CYS SER LEU SEQRES 8 A 345 LYS VAL SER LEU GLN LEU ARG GLY GLU ASP GLY SER VAL SEQRES 9 A 345 TRP ASN TYR LYS PRO PRO ALA ASP SER GLY GLY LYS GLU SEQRES 10 A 345 ILE PHE SER LEU LEU PRO HIS MET ALA ASP MET SER THR SEQRES 11 A 345 TYR MET PHE LYS GLY ILE ILE SER PHE ALA LYS VAL ILE SEQRES 12 A 345 SER TYR PHE ARG ASP LEU PRO ILE GLU ASP GLN ILE SER SEQRES 13 A 345 LEU LEU LYS GLY ALA ALA PHE GLU LEU CYS GLN LEU ARG SEQRES 14 A 345 PHE ASN THR VAL PHE ASN ALA GLU THR GLY THR TRP GLU SEQRES 15 A 345 CYS GLY ARG LEU SER TYR CYS LEU GLU ASP THR ALA GLY SEQRES 16 A 345 GLY PHE GLN GLN LEU LEU LEU GLU PRO MET LEU LYS PHE SEQRES 17 A 345 HIS TYR MET LEU LYS LYS LEU GLN LEU HIS GLU GLU GLU SEQRES 18 A 345 TYR VAL LEU MET GLN ALA ILE SER LEU PHE SER PRO ASP SEQRES 19 A 345 ARG PRO GLY VAL LEU GLN HIS ARG VAL VAL ASP GLN LEU SEQRES 20 A 345 GLN GLU GLN PHE ALA ILE THR LEU LYS SER TYR ILE GLU SEQRES 21 A 345 CYS ASN ARG PRO GLN PRO ALA HIS ARG PHE LEU PHE LEU SEQRES 22 A 345 LYS ILE MET ALA MET LEU THR GLU LEU ARG SER ILE ASN SEQRES 23 A 345 ALA GLN HIS THR GLN ARG LEU LEU ARG ILE GLN ASP ILE SEQRES 24 A 345 HIS PRO PHE ALA THR PRO LEU MET GLN GLU LEU PHE GLY SEQRES 25 A 345 ILE THR GLY SER LEU VAL PRO ARG GLY SER SER SER HIS SEQRES 26 A 345 SER SER LEU THR GLU ARG HIS LYS ILE LEU HIS ARG LEU SEQRES 27 A 345 LEU GLN GLU GLY SER PRO SER SEQRES 1 B 345 MET LYS LYS GLY HIS HIS HIS HIS HIS HIS GLY SER GLU SEQRES 2 B 345 ARG THR GLY THR GLN PRO LEU GLY VAL GLN GLY LEU THR SEQRES 3 B 345 GLU GLU GLN ARG MET MET ILE ARG GLU LEU MET ASP ALA SEQRES 4 B 345 GLN MET LYS THR PHE ASP THR THR PHE SER HIS PHE LYS SEQRES 5 B 345 ASN PHE ARG LEU PRO GLY VAL LEU SER SER GLY CYS GLU SEQRES 6 B 345 LEU PRO GLU SER LEU GLN ALA PRO SER ARG GLU GLU ALA SEQRES 7 B 345 ALA LYS TRP SER GLN VAL ARG LYS ASP LEU CYS SER LEU SEQRES 8 B 345 LYS VAL SER LEU GLN LEU ARG GLY GLU ASP GLY SER VAL SEQRES 9 B 345 TRP ASN TYR LYS PRO PRO ALA ASP SER GLY GLY LYS GLU SEQRES 10 B 345 ILE PHE SER LEU LEU PRO HIS MET ALA ASP MET SER THR SEQRES 11 B 345 TYR MET PHE LYS GLY ILE ILE SER PHE ALA LYS VAL ILE SEQRES 12 B 345 SER TYR PHE ARG ASP LEU PRO ILE GLU ASP GLN ILE SER SEQRES 13 B 345 LEU LEU LYS GLY ALA ALA PHE GLU LEU CYS GLN LEU ARG SEQRES 14 B 345 PHE ASN THR VAL PHE ASN ALA GLU THR GLY THR TRP GLU SEQRES 15 B 345 CYS GLY ARG LEU SER TYR CYS LEU GLU ASP THR ALA GLY SEQRES 16 B 345 GLY PHE GLN GLN LEU LEU LEU GLU PRO MET LEU LYS PHE SEQRES 17 B 345 HIS TYR MET LEU LYS LYS LEU GLN LEU HIS GLU GLU GLU SEQRES 18 B 345 TYR VAL LEU MET GLN ALA ILE SER LEU PHE SER PRO ASP SEQRES 19 B 345 ARG PRO GLY VAL LEU GLN HIS ARG VAL VAL ASP GLN LEU SEQRES 20 B 345 GLN GLU GLN PHE ALA ILE THR LEU LYS SER TYR ILE GLU SEQRES 21 B 345 CYS ASN ARG PRO GLN PRO ALA HIS ARG PHE LEU PHE LEU SEQRES 22 B 345 LYS ILE MET ALA MET LEU THR GLU LEU ARG SER ILE ASN SEQRES 23 B 345 ALA GLN HIS THR GLN ARG LEU LEU ARG ILE GLN ASP ILE SEQRES 24 B 345 HIS PRO PHE ALA THR PRO LEU MET GLN GLU LEU PHE GLY SEQRES 25 B 345 ILE THR GLY SER LEU VAL PRO ARG GLY SER SER SER HIS SEQRES 26 B 345 SER SER LEU THR GLU ARG HIS LYS ILE LEU HIS ARG LEU SEQRES 27 B 345 LEU GLN GLU GLY SER PRO SER HET SRL A 501 33 HET SRL B 501 33 HETNAM SRL [2-(3,5-DI-TERT-BUTYL-4-HYDROXY-PHENYL)-1-(DIETHOXY- HETNAM 2 SRL PHOSPHORYL)-VINYL]-PHOSPHONIC ACID DIETHLYL ESTER HETSYN SRL SR12813 FORMUL 3 SRL 2(C24 H42 O7 P2) FORMUL 5 HOH *43(H2 O) HELIX 1 AA1 THR A 144 PHE A 162 1 19 HELIX 2 AA2 ARG A 193 SER A 208 1 16 HELIX 3 AA3 GLY A 233 SER A 238 5 6 HELIX 4 AA4 LEU A 239 ILE A 261 1 23 HELIX 5 AA5 ILE A 261 ASP A 266 1 6 HELIX 6 AA6 PRO A 268 THR A 290 1 23 HELIX 7 AA7 GLN A 317 LEU A 320 5 4 HELIX 8 AA8 GLU A 321 GLN A 334 1 14 HELIX 9 AA9 HIS A 336 PHE A 349 1 14 HELIX 10 AB1 GLN A 358 ARG A 381 1 24 HELIX 11 AB2 PHE A 388 HIS A 418 1 31 HELIX 12 AB3 THR A 422 PHE A 429 1 8 HELIX 13 AB4 HIS A 450 GLU A 459 1 10 HELIX 14 AB5 THR B 144 PHE B 162 1 19 HELIX 15 AB6 ALA B 196 CYS B 207 1 12 HELIX 16 AB7 GLY B 233 SER B 238 5 6 HELIX 17 AB8 LEU B 239 ILE B 261 1 23 HELIX 18 AB9 ILE B 261 ASP B 266 1 6 HELIX 19 AC1 PRO B 268 THR B 290 1 23 HELIX 20 AC2 PHE B 315 LEU B 319 1 5 HELIX 21 AC3 GLU B 321 LEU B 333 1 13 HELIX 22 AC4 HIS B 336 PHE B 349 1 14 HELIX 23 AC5 GLN B 358 ARG B 381 1 24 HELIX 24 AC6 GLN B 383 ARG B 387 5 5 HELIX 25 AC7 PHE B 388 HIS B 418 1 31 HELIX 26 AC8 THR B 422 GLY B 430 1 9 HELIX 27 AC9 HIS B 450 GLU B 459 1 10 SHEET 1 AA110 PHE A 292 ASN A 293 0 SHEET 2 AA110 THR A 298 CYS A 301 -1 O THR A 298 N ASN A 293 SHEET 3 AA110 LEU A 304 LEU A 308 -1 O TYR A 306 N TRP A 299 SHEET 4 AA110 VAL A 211 ARG A 216 -1 N GLN A 214 O SER A 305 SHEET 5 AA110 VAL A 222 LYS A 226 -1 O TYR A 225 N LEU A 213 SHEET 6 AA110 VAL B 222 LYS B 226 -1 O LYS B 226 N VAL A 222 SHEET 7 AA110 VAL B 211 ARG B 216 -1 N LEU B 213 O TYR B 225 SHEET 8 AA110 LEU B 304 LEU B 308 -1 O SER B 305 N GLN B 214 SHEET 9 AA110 THR B 298 CYS B 301 -1 N TRP B 299 O TYR B 306 SHEET 10 AA110 PHE B 292 ASN B 293 -1 N ASN B 293 O THR B 298 CISPEP 1 GLN A 383 PRO A 384 0 -5.74 CRYST1 85.420 89.030 106.660 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011707 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011232 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009376 0.00000